Advanced age no barrier to continuous myeloma regimen
Posted on: 26/06/2015 - 13:08
VIENNA – Elderly patients over age 75 with newly diagnosed multiple myeloma derive the same survival benefits from continuous lenalidomide and low-dose dexamethasone as those under 75, according to a...
Field of Interest: Oncology
Type: News Item